These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9229726)

  • 21. [Antifungal drug susceptibility of Candida causing oropharyngeal candidiasis in HIV infected patients].
    Dieng Y; Faye-Niang MA; Ndour-Diop A; Sow PS; Dieng T; Soumare M; Bah IB; Faye O; Diop BM; Gaye O; Ndir O; Diallo S
    Dakar Med; 2001; 46(1):4-7. PubMed ID: 15773146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.
    Luque AG; Biasoli MS; Tosello ME; Binolfi A; Lupo S; Magaró HM
    Mycoses; 2009 Jan; 52(1):53-9. PubMed ID: 18498298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
    Nébavi F; Arnavielhe S; Le Guennec R; Ménan E; Kacou A; Combe P; Aoussi E; Mallié M; Koné M; Bastide JM
    Pathol Biol (Paris); 1998 May; 46(5):307-14. PubMed ID: 9769890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics.
    Schmidt-Westhausen AM; Bendick C; Reichart PA; Samaranayake LP
    Mycoses; 2004 Oct; 47(9-10):435-41. PubMed ID: 15504130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
    Bulacio L; Paz M; Ramadán S; Ramos L; Pairoba C; Sortino M; Escovich L; López C
    J Mycol Med; 2012 Dec; 22(4):348-53. PubMed ID: 23518170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus.
    Bremenkamp RM; Caris AR; Jorge AO; Back-Brito GN; Mota AJ; Balducci I; Brighenti FL; Koga-Ito CY
    Arch Oral Biol; 2011 Jun; 56(6):549-55. PubMed ID: 21183157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multicenter study on nosocomial candidiasis in the Republic of Argentina].
    Rodero L; Davel G; Córdoba S; Soria M; Canteros C; Hochenfellner F
    Rev Argent Microbiol; 1999; 31(3):114-9. PubMed ID: 10509389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral candidiasis of HIV-infected children undergoing sequential HIV therapies.
    Melo NR; Taguchi H; Culhari VP; Kamei K; Mikami Y; Smith SN; Vilela MS
    Med Mycol; 2009 Mar; 47(2):149-56. PubMed ID: 18651304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.
    Brown DM; Jabra-Rizk MA; Falkler WA; Baqui AA; Meiller TF
    Pediatr Dent; 2000; 22(3):234-8. PubMed ID: 10846737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiology of fungaemia and catheter colonisation in Argentinean paediatric patients.
    Giusiano G; Mangiaterra M; Saito VG; Rojas F; Gómez V; Díaz MC
    Mycoses; 2006 Jan; 49(1):49-54. PubMed ID: 16367819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds].
    Manzano-Gayosso P; Méndez-Tovar LJ; Arenas R; Hernández-Hernández F; Millán-Chiu B; Torres-Rodríguez JM; Cortés-González E; Fernández R; López-Martínez R
    Rev Iberoam Micol; 2011; 28(1):32-5. PubMed ID: 21147249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Etiological factors of fungemia in the Hospital San Martín in La Plata].
    Mestroni SC; Verna JA; Smolkin A; Bava AJ
    Rev Argent Microbiol; 2003; 35(2):106-9. PubMed ID: 12920994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of fungal isolates in patients with chronic diarrhea at a tertiary care hospital in north India.
    Banerjee P; Kaur R; Uppal B
    J Mycol Med; 2013 Mar; 23(1):21-6. PubMed ID: 23375861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
    Still JM; Law EJ; Belcher KE; Spencer SA
    Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
    J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.